Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs
PositiveFinancial Markets

Takeda Pharmaceutical Co. has partnered with China's Innovent Biologics Inc. to co-develop cancer therapies, highlighting a growing trend among global pharmaceutical companies to collaborate with Chinese biotech firms. This deal is significant as it reflects the increasing importance of innovation in the fight against cancer and the potential for these collaborations to lead to groundbreaking treatments.
— Curated by the World Pulse Now AI Editorial System